LHCGR and polycystic ovary syndrome: A limited number of functional studies have evaluated the role of several of the newly identified PCOS risk loci, including LHCGR (Luteinizing hormone/choriogonadotropin receptor) and DENND1A (DENN/MADD domain containing 1A) [11–13].